SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-253167
Filing Date
2024-11-07
Accepted
2024-11-07 16:27:56
Documents
2
Group Members
CHEN YUTCG CROSSOVER FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d791430dsc13g.htm SC 13G 74572
2 EX-99.1 d791430dex991.htm EX-99.1 4625
  Complete submission text file 0001193125-24-253167.txt   81027
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81613 | Film No.: 241436276
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 705 HIGH STREET PALO ALTO CA 94301
Business Address 705 HIGH STREET PALO ALTO CA 94301 650-924-9424
TCG Crossover GP II, LLC (Filed by) CIK: 0001969280 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G